ArticleFrontiers in microbiology2025
Unique pathological features and drug resistance patterns in cutaneous tuberculosis.
Article in Frontiers in microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Diagnostic Imaging of Extrapulmonary Tuberculosis Across Organ Systems.Diagnostics (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cutaneous tuberculosis (CTB), a rare manifestation of extrapulmonary tuberculosis, often presents diagnostic challenges in clinical settings due to its atypical presentation. The definitive diagnosis relies heavily on pathological evaluation, which underscores the importance of understanding the distinct pathological characteristics and drug resistance patterns of CTB, a subject that has not been extensively explored previously. In this study, we conducted a comparative analysis of 59 CTB samples and 59 pulmonary tuberculosis samples, focusing on their clinicopathological features. Our findings reveal that CTB can be characterized by subcutaneous irregular hypoechoic regions on ultrasound, localized soft tissue swelling, and flaky low-density shadows on CT scans, with MRI effectively determining the extent of bone and soft tissue involvement. The two groups had no statistical difference in the positivity rate for acid-fast staining and molecular detection. Notably, the incidence of granulomatous lesions was higher in CTB compared to pulmonary tuberculosis, and the high number of macrophages in the skin may be an important reason. However, other parameters such as caseous necrosis, coagulative necrosis, inflammatory necrosis, acute inflammation, hemorrhage, fibroplasia, and exudation showed no significant differences between the two groups. Intriguingly, many significant differences in drug resistance patterns were found between the CTB group and the control group. But when comparing the secondary CTB group to the control group, the only significant difference found was in resistance to RFP + INH + STR. Overall, our study highlights unique pathological features and drug resistance profiles in CTB, providing valuable insights for more accurate clinical diagnosis and tailored therapeutic strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.